<DOC>
	<DOCNO>NCT02594358</DOCNO>
	<brief_summary>Prospective data visual acuity response child treat patch concurrently treat caffeine estimate magnitude effect might see randomize trial ( improvement acuity see , would sufficient evidence decide conduct randomize , double blind trial ) . Collect prospective data tolerability caffeine two dosage adjuvant treatment amblyopia provide limit data safety . Evaluate potential dietary intervention enhance acceptance tolerability patch child family . Demonstrate recruitment potential subject participate dietary intervention study .</brief_summary>
	<brief_title>Caffeine Amblyopia Study</brief_title>
	<detailed_description />
	<mesh_term>Amblyopia</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<criteria>Amblyopia strabismus amblyopia Known intolerance caffeine Diagnosis and/or treatment attention deficit/hyperactivity disorder Presence ocular cause reduce visual acuity Myopia special equivalent 6.00 diopter Current vision therapy orthoptics type Ocular cause reduce visual acuity Prior intraocular refractive surgery History narrowangle glaucoma Strabismus surgery plan within 16 week Nystagmus per se exclude subject visual acuity criterion meet Known skin reaction patch bandage adhesive Known allergy intolerance food dye Current treatment topical atropine eyedrop Menarche , pregnancy lactation Use follow medication may affect caffeine metabolism : nafcillin , verapamil , fluvoxamine , ciprofloxacin fluoroquinolones , modafinil , nafcillin , omeprazole</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>13 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Caffeine</keyword>
</DOC>